ApprovalTrail

Approval · Notice of Compliance 8352 · 2006

GLICLAZIDE: Notice of Compliance 8352

Issued October 25, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
8352
Date
October 25, 2006
Company
Genpharm Inc.Etobicoke, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Additional product name
Therapeutic class
Oral hypoglycemic agent

Products in this notice

BrandDINStatus today
GLICLAZIDE02287072Marketed

Medicinal ingredients